Methylene blue has been shown to shrink cancer tumours

Methylene blue has been shown to shrink tumours and slow cancer growth by targeting cancer cell metabolism and energy production.

Photodynamic therapy with methylene blue uses light activation to destroy cancer cells while leaving healthy cells unharmed, making it a more precise treatment option.

Research on ovarian cancer found that methylene blue forces tumours to shift away from their preferred energy source, making them more vulnerable to treatment.

Unlike chemotherapy, methylene blue treatment does not cause significant side effects or toxicity, making it a promising option for patients with drug-resistant cancers.

TRUTH LIVES on athttps://sgtreport.tv/

Proper dosing is important. Just 5 milligrams of pharmaceutical-grade methylene blue per day is enough to reduce cellular stress and support mitochondrial health.

Conventional cancer treatments often come with debilitating side effects. For example, chemotherapy and radiation therapy not only target tumours but also damage healthy cells, leaving patients weakened and vulnerable to infections. In an effort to find safer treatment options for patients, researchers are now testing the efficacy of methylene blue – a commonly used dye that enhances cellular energy production – in treating cancer.

A systematic review published inFrontiers in Pharmacologyanalysed the effects of methylene blue in photodynamic therapy for cancer treatment. Researchers reviewed 10 preclinical studies from different countries assessing how methylene blue, when activated by light, impacts tumour growth.

• Methylene blue targets different cancers.The analysis covered different types of cancer, including colorectal tumours, melanoma and carcinoma, highlighting methylene blue’s ability to shrink tumours through a highly targeted mechanism that spares healthy tissue. A total of 133 mice were used, with 59 receiving methylene blue photodynamic therapy and 74 serving as untreated controls.1

• Antitumour properties of methylene blue.The researchers found that methylene blue significantly reduced tumour sizes in seven of the 10 studies, with reductions ranging from 12% to complete tumour elimination.

Source: SGT Report